Issue 69, 2018

Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

Abstract

A novel and efficient branch PCR strategy has been used to construct a TP53 gene nanovector based on a pair of trimers as primers, which showed unique advantages compared to other existing systems for gene delivery and effective potential cancer therapy.

Graphical abstract: Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
26 Jun 2018
Accepted
31 Jul 2018
First published
01 Aug 2018

Chem. Commun., 2018,54, 9687-9690

Branch-PCR constructed TP53 gene nanovector for potential cancer therapy

L. Cheng, H. Deng, D. Ma, B. Zhai, Q. Zhang, L. Li and Z. Xi, Chem. Commun., 2018, 54, 9687 DOI: 10.1039/C8CC05066J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements